23andMe — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.
BiotechFemTechHealthtechMedical DevicesAustin, US
Dina Turner(Co-founder & Chief Executive Officer)inMartin Varsavsky(Co-founder & Chairman)inDina Radenkovic(Founder)inMartín Varsavsky(Founder)
BoardDusan Perovic(Director)inDylan Morris(Director)in
Co-investorsBold Capital PartnersDeviation CapitalFJ LabsFuture VenturesIngeborg InvestmentsInsight Partners+18 more
MIDI develops digital health solutions for patients and clinicians to improve access to and delivery of care across diverse populations.
Digital HealthHealthtechLos Altos Hills, US
Joanna Stober(Executive Officer, Director)Sharon Meers(President & Co-founder)inJoanna Strober(Founder)inKathleen Jordan MD(Chief Medical Officer & Co-founder)inKathleen Jordan(Founder)
BoardAllison Gates(Director)in
Co-investors1843 Capital25MadisonAble PartnersAdvance Venture PartnersAvestria VenturesCity Light+19 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















